– Advertisement –

Patients in the EU should have access to the medicines they need, when they need them. Unfortunately, in recent years EU countries have been confronted with severe medicine shortages, made worse by global events such as the COVID-19 pandemic. The Critical Medicines Act, proposed by the Commission today, aims to support manufacturing and improve the availability of critical medicines in the EU.

Medicine shortages are mostly caused by manufacturing problems, supply chain risks and global competition for resources. The new Act aims to overcome these challenges. Key elements include

• improving EU manufacturing capacity for critical medicines through strategic projects
• use of public procurement to encourage reliable supply chains of critical medicines or improve access to other medicines
• supporting collaborative procurement among EU countries to ensure fair access to important medicines across the EU
• exploring international partnerships to reduce dependence on a single or limited number of suppliers

Tackling shortages and ensuring access to medicines has been a priority for the EU for many years. The new Critical Medicines Act complements legislative proposals already put forward to address this, notably through the reform of the EU’s pharmaceutical strategy. The European Medicines Agency, together with national authorities, plays a key role in monitoring and responding to these critical medicine shortages.

For more information

Press release: Commission proposes Critical Medicines Act to bolster the supply of critical medicines in the EU

Questions and answers on the Critical Medicines Act

Factsheet on Critical Medicines Act

Modernising the EU pharmaceutical legislation

European Medicines Agency

European Critical Medicines Alliance

About Us

Popular Category

DISCLAIMER OPINIONS: The opinions of the authors or reproduced in the articles are the ones of those stating them and it is their own responsibility. Should you find any incorrections you can always contact the newsdesk to seek a correction or right of replay.

DISCLAIMER TRANSLATIONS: All articles in this site are published in English. The translated versions are done through an automated process known as neural translations. If in doubt, always refer to the original article. Thank you for understanding.

DISCLAIMER PHOTOS: We mostly used photos images that are readily available online, from free sources, or from the people promoting the news. If by any chance it happens that we have used one of your copyrighted photos, please do not hesitate to contact us and we will take it down without question. We do not make profits as this is a not for profit project to give voice to the voiceless while giving them a platform to be informed also of general news, and it is completely free.